electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.
企業コードECOR
会社名electroCore, Inc.
上場日Jun 22, 2018
最高経営責任者「CEO」Mr. Daniel S. Goldberger
従業員数73
証券種類Ordinary Share
決算期末Jun 22
本社所在地200 Forge Way
都市ROCKAWAY
証券取引所London Stock Exchange
国United States of America
郵便番号07866
電話番号19732900097
ウェブサイトhttps://www.electrocore.com/
企業コードECOR
上場日Jun 22, 2018
最高経営責任者「CEO」Mr. Daniel S. Goldberger
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし